These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16475043)

  • 1. The standard is still the standard or why an INR of 2-3 is still the optimal intensity for secondary prevention of venous thromboembolism.
    Kovacs MJ
    J Thromb Thrombolysis; 2006 Feb; 21(1):53-6. PubMed ID: 16475043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low intensity warfarin anticoagulation is safe and effective as a long-term venous thromboembolism prevention strategy.
    Goldhaber SZ
    J Thromb Thrombolysis; 2006 Feb; 21(1):51-2. PubMed ID: 16475042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
    N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low intensity warfarin: is it clinically useful in venous thromboembolism management?
    Bauer KA
    Br J Haematol; 2004 Oct; 127(2):155-8. PubMed ID: 15461620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial.
    Ridker PM
    Vasc Med; 1998; 3(1):67-73. PubMed ID: 9666536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The perioperative management of warfarin therapy.
    Ansell JE
    Arch Intern Med; 2003 Apr; 163(8):881-3. PubMed ID: 12719195
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective assessment of a nomogram for the initiation of oral anticoagulation therapy for outpatient treatment of venous thromboembolism.
    Kovacs MJ; Anderson DA; Wells PS
    Pathophysiol Haemost Thromb; 2002; 32(3):131-3. PubMed ID: 12372927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis.
    Meroni PL; Moia M; Derksen RH; Tincani A; McIntyre JA; Arnout JM; Koike T; Piette JC; Khamashta MA; Shoenfeld Y
    Lupus; 2003; 12(7):504-7. PubMed ID: 12892388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative management of patients receiving oral anticoagulants.
    Kearon C; Hirsh J
    Arch Intern Med; 2003 Nov; 163(20):2532-3; author reply 2533. PubMed ID: 14609792
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
    Enyart JJ; Jones RJ
    Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences of a low-intensity anticoagulation regimen for extended secondary prevention of venous thromboembolism.
    Svensson P; Södermark A; Schulman S
    Hematol J; 2002; 3(6):311-4. PubMed ID: 12522454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplasty.
    Clark NP; Cho SE; Delate T; Witt DM
    Thromb Res; 2013 May; 131(5):390-5. PubMed ID: 23522854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism.
    Nordstrom BL; Kachroo S; Fraeman KH; Nutescu EA; Schein JR; Fisher A; Bookhart BK
    Curr Med Res Opin; 2011 Oct; 27(10):1973-85. PubMed ID: 21919556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will a once-weekly anticoagulant for the treatment and secondary prevention of thromboembolism improve adherence?
    Cohen AT; Maillardet L; Yavin Y
    Thromb Haemost; 2009 Mar; 101(3):422-7. PubMed ID: 19277401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
    Finazzi G; Marchioli R; Brancaccio V; Schinco P; Wisloff F; Musial J; Baudo F; Berrettini M; Testa S; D'Angelo A; Tognoni G; Barbui T
    J Thromb Haemost; 2005 May; 3(5):848-53. PubMed ID: 15869575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulation: improving the risk-benefit ratio.
    Vanscoy GJ; Coax WC
    J Fam Pract; 1995 Sep; 41(3):261-9. PubMed ID: 7650506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease.
    Kovacs MJ; Cruickshank M; Wells PS; Kim H; Chin-Yee I; Morrow B; Boyle E; Kovacs J
    Haemostasis; 1998; 28(2):62-9. PubMed ID: 10087430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.